Mir-125b is a suppressor of both P53 and P14ARF, as seen in steps 5a and 5b of Fig
Hospital tests showed I had a fatty liver, high blood pressure, and raised cholesterol
Neither drug is a cure for obesity or any other health conditions, but they may support weight loss goals as part of a broader treatment plan that includes a calorie-restricted diet, physical activity, and lifestyle changes
They work on entirely different things, so a direct comparison is tricky
Phase (approx.) Cagrilintide dose Frequency Weeks 14 0.25 mg Once weekly Weeks 58 0.5 mg Once weekly Weeks 912 1.0 mg Once weekly Weeks 1316 1.7 mg Once weekly Week 17 onward 2.4 mg (max studied) Once weekly This step-wise schedule mirrors the titration used in cagrilintide and CagriSema studies ( Lau et al., Lancet 2021
Wnt5a activats Wnt/PCP pathway, upregulating Ras-related C3 botulinum toxin substrate 1(Rac), which can activate JNK, thus aggravating IR in adipose tissue